.
MergerLinks Header Logo

New Deal


Announced

Completed

Avista Capital-backed Solmetex completed the acquisition of Impladent.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Single Bidder

Friendly

Private

United States

Medical Supplies

innovative dental bone grafting

Acquisition

Domestic

Private Equity

Majority

Completed

Synopsis

Edit

Avista Capital-backed Solmetex, a manufacturer and supplier of amalgam separators and other waste compliance products, completed the acquisition of Impladent, a provider of a broad range of innovative and affordable regenerative materials including bone grafts and resorbable membranes used in tooth extraction procedures. Financial terms were not disclosed. "We are proud to partner with a leader and innovator in regenerative dental technology. We believe the addition of Impladent to our offering will unlock meaningful growth in new areas. I look forward to the opportunity to collaborate with the Impladent team and execute on our plans for future expansion." Gene Dorff, Solmetex Chief Executive Officer.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US